FDA Approves Groundbreaking Drug for Pancreatic Cancer
26.08.2026, 20:00
The U.S. Food and Drug Administration has approved a new drug, Daraxonrasib, for the treatment of metastatic pancreatic cancer, marking a significant milestone in the fight against this deadly disease. This landmark approval is expected to transform the treatment landscape, offering new hope to...